Mesoblast is pretty busy atm and juggling with 4 shots at goal:
- Ryoncil -
- C19 ARDS
- CHF
- CLBP
The best thing you can do is judge each indication on their own merits.
"the past negative views of FDA" - on which indication? What is the specific negative FDA view on this indication?
Thursday 15th July - NEJM, page-57
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.165(12.2%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $19.62M | 13.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1570 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 12240 | 7 |
View Market Depth
| Last trade - 14.53pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |